FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Suspect arrested for allegedly running meth lab at Michigan State University’s largest academic building

Two Kentucky bank employees shot and killed during robbery, police hunting suspect

Dominican migrant with deportation order, wanted for murder in home country freed by Biden-appointed judge

Wyoming official faces backlash after posting ‘hang bad judges’ comment on abortion ruling

Doctor and son accused of running dangerous side-business scheme in New York

DOJ sues New Jersey over laws giving illegal aliens in-state tuition, says citizens treated as ‘second-class’

Hawley champions GUARD Act as heartbroken families say AI chatbots allegedly pushed teens to self-harm

Democratic Congressman Suggests Execution for Pete Hegseth

GOP lawmakers seek to defund HBCU after it canceled Republican’s commencement speech

DOJ Axes a Slew of Gun-Control Regulations in ‘Historic’ Day for the 2nd Amendment

Watch: Johnny Carson’s Reaction to Reagan Shooting Goes Viral After Trump Targeted

MN lawmakers unload on Walz’s ‘legacy’ after he touts fraud record in final annual address: ‘Ridiculous’

DNC chair ripped for downplaying unreleased 2024 autopsy after Dem losses: ‘Self-inflicted crisis’

US National Debt Exceeds GDP for First Time Since the Immediate Aftermath of WWII

DOJ weighs new classified leak charges against Comey as legal pressure escalates

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”